1 active not recruiting, 1 completed, 1 recruiting, 1 unknown. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Active not recruiting 1, Completed 1, Recruiting 1, Unknown 1 |
Follow Hodgkin Lymphoma: new trials by email Literature Review of Hodgkin Lymphoma trials Research Report on Hodgkin Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India Brentuximab Vedotin, Doxorubicin, Vinblastine - Hodgkin Lymphoma | Phase 4 | Recruiting | Takeda | 124 | 2024-08-28 | 2026-02-23 |
| Enhancing Effect on Tumour Apoptosis With the Use of Pentoxifylline in Patients With Hodgkin Lymphoma Pentoxifylline, Placebo - Hodgkin Lymphoma | Phase 4 | Unknown | University of Guadalajara | 30 | 2022-07-11 | 2023-04-18 |
| CCCG-HD-2018 for Children and Adolescents With Newly Diagnosed Hodgkin Lymphoma Combined chemotherapy with or without involved-field radiotherapy - Hodgkin Lymphoma | Phase 4 | Active not recruiting | Children's Cancer Group, China | 200 | 2018-04-01 | 2026-03-19 |
| A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma Brentuximab Vedotin - Hodgkin Lymphoma | Phase 4 | Completed | Millennium Pharmaceuticals, Inc. | 60 | 2014-03-14 | 2021-04-09 |
Hodgkin Disease (4) · Lymphoma (2) · Hematologic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma, B-Cell (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, T-Cell (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Recurrence (1)
Hemic and Lymphatic Diseases (4) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Lymphatic Diseases (3) · Lymphoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Lymphoma (2) · Disease Attributes (1) · Lymphoma, Non-Hodgkin (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Brentuximab Vedotin (2) · Dacarbazine (1) · Doxorubicin (1) · Pentoxifylline (1) · Vinblastine (1)
Children's Cancer Group, China (1) · Millennium Pharmaceuticals, Inc. (1) · Takeda (1) · University of Guadalajara (1)
China (1) · Czechia (1) · Germany (1) · India (1) · Malaysia (1) · Mexico (1) · Poland (1) · Spain (1) · Thailand (1) · Turkey (Türkiye) (1)